GENF vs. RLM, POLB, NSCI, IMM, SNG, IXI, BVX, OBD, HEMO, and FAB
Should you be buying Genflow Biosciences stock or one of its competitors? The main competitors of Genflow Biosciences include Realm Therapeutics (RLM), Poolbeg Pharma (POLB), NetScientific (NSCI), ImmuPharma (IMM), Synairgen (SNG), IXICO (IXI), BiVictriX Therapeutics (BVX), Oxford BioDynamics (OBD), Hemogenyx Pharmaceuticals (HEMO), and Fusion Antibodies (FAB). These companies are all part of the "biotechnology" industry.
Genflow Biosciences vs.
Genflow Biosciences (LON:GENF) and Realm Therapeutics (LON:RLM) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, valuation, analyst recommendations, media sentiment, earnings, profitability, risk and dividends.
Genflow Biosciences has a net margin of 778.46% compared to Realm Therapeutics' net margin of 0.00%. Realm Therapeutics' return on equity of 0.00% beat Genflow Biosciences' return on equity.
9.2% of Genflow Biosciences shares are held by institutional investors. 64.2% of Genflow Biosciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Realm Therapeutics has higher revenue and earnings than Genflow Biosciences. Genflow Biosciences is trading at a lower price-to-earnings ratio than Realm Therapeutics, indicating that it is currently the more affordable of the two stocks.
Realm Therapeutics received 193 more outperform votes than Genflow Biosciences when rated by MarketBeat users.
In the previous week, Genflow Biosciences had 1 more articles in the media than Realm Therapeutics. MarketBeat recorded 1 mentions for Genflow Biosciences and 0 mentions for Realm Therapeutics. Genflow Biosciences' average media sentiment score of 0.00 equaled Realm Therapeutics'average media sentiment score.
Summary
Genflow Biosciences and Realm Therapeutics tied by winning 5 of the 10 factors compared between the two stocks.
Get Genflow Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for GENF and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Genflow Biosciences Competitors List
Related Companies and Tools
This page (LON:GENF) was last updated on 5/1/2025 by MarketBeat.com Staff
Buy GENF Stock Free GENF Stock Alerts